LSLiu Sun

Liu Sun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Liu Sun has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Shanghua Fan

    Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China

    5 shared publications
  • Jian Yang

    Department of Computer Science School of Engineering Yuxi Normal University Yuxi China yxnu.net

    4 shared publications
  • Ting Zhao

    Department of Neurology, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, China

    4 shared publications
  • Gang Peng

    State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University

    3 shared publications
  • Changwen Zhang

    Institutes of Brain Science and State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai 200032, China

    2 shared publications
  • Hang-Jing Wu

    Zhejiang University

    2 shared publications

Latest Publications

  • Open Access

    Estimation of the genetic susceptibility prevalence of primary ciliary dyskinesia via the gnomAD v4.1.0 database

    by Rutao Dai, Ya Dao, Xichen Zhang, Yongyu Ma, Xian Zhu, Yunshan Gao, Jun Wu, Liu Sun

    Background: Primary ciliary dyskinesia (PCD) is a rare genetic disorder that is predominantly inherited in an autosomal recessive pattern and is caused by structural or functional ciliary abnormalities. Previous studies on the genetic susceptibility prevalence of PCD have been largely based on limited populations, and there is a lack of global estimates derived from large-scale population genetic databases. This study estimates the carrier frequency and genetic susceptibility prevalence of PCD via the latest data from the gnomAD v4.1.0 database and compares the results with those of previous studies. Methods: We selected genes related to PCD with “Definitive” or “Strong” associations as determined by the ClinGen Motile Ciliopathy Gene Curation Expert Panel. According to ACMG/AMP guidelines, variables were classified for pathogenicity, including loss-of-function variants (pLOFs) and pathogenic/likely pathogenic missense variants. Using the allele frequency (AF) of these variants from the Genome Aggregation Database (gnomAD) v4.1.0 (containing data from 807,162 individuals) and applying the Hardy‒Weinberg equilibrium principle, we calculated the global and population-specific genetic susceptibility prevalence and carrier frequency of PCD. Results: Among the 31 PCD-associated genes, 5252 eligible variants were included, comprising 5156 pLOF and 96 P/LP variants. The estimated global genetic susceptibility prevalence of PCD is approximately 1 in 20,103, with a corresponding overall carrier frequency of approximately 1 in 25. The Middle East region has the highest prevalence rate of 1 in 4,744, as well as the highest carrier frequency. Conclusion: The estimated global genetic susceptibility prevalence of primary ciliary dyskinesia is approximately 1 in 20,103, with an overall carrier frequency of 1 in 25, indicating significant heterogeneity among ethnic populations. The global genetic susceptibility prevalence estimate is lower than the previous estimate of 1/7,554.

  • Open Access

    VarSim: A Python Toolkit for HGVS Variant Description Validation, Normalization, and Representation Conversion

    by Liu Sun, Rongshu Wang, Jian Yang

    Accurate and reproducible representation of genetic variants is essential for clinical genomics, variant databases, and genomic research. The Human Genome Variation Society (HGVS) recommendations provide a standardized framework for describing sequence variants, but practical HGVS processing commonly involves multiple interdependent tasks, including parsing, validation, normalization, coordinate transformation, protein consequence inference, and conversion between variant representation formats. We developed VarSim, a lightweight Python toolkit that integrates these operations within a reference‐aware workflow based on version‐pinned Matched Annotation from NCBI and EMBL‐EBI (MANE) transcripts retrieved from NCBI Entrez. VarSim provides programmatic functions for HGVS parsing, syntactic and semantic validation, normalization, sequence extraction, backtranslation, coordinate mapping, protein consequence prediction, genome‐assembly liftover, and conversion between HGVS, VCF, and SPDI representations. We benchmarked the toolkit using 1458 HGVS descriptions across five MANE transcripts, comprising 500 coding single‐nucleotide variants, 250 frameshift insertions/deletions, and 708 intronic splice‐site substitutions. All 1458 descriptions passed VarSim syntactic validation, and all 750 coding descriptions passed semantic validation against the corresponding reference sequences. VariantValidator accepted all 1458 descriptions, whereas the Mutalyzer normalization endpoint processed the 750 coding descriptions. VarSim normalization agreed with Mutalyzer for all 750 coding variants and with VariantValidator for 749 of 750 variants. Protein consequence predictions agreed with VariantValidator for all 500 coding single‐nucleotide variants. Format conversion between HGVS, VCF, and SPDI was exact for the tested variants, whereas transcript‐to‐genome projection showed substantial discrepancies relative to VariantValidator and therefore remains a limitation of the current implementation. VarSim provides a complementary, programmatic framework for reproducible HGVS processing and variant representation interoperability.

  • Optimizing Low-Resource Multilingual Speech Translation: From Data Augmentation to Plug-in Model Design for High-Speed Environments

    by Jian Yang, Yingying Yue, Liu Sun

    This study tackles the challenge of speech translation in low-resource, multiethnic language settings — using Hani as a representative case — by proposing an optimized plug-in model structure within a pretraining and fine-tuning paradigm. To address the scarcity of annotated corpus and the imbalanced distribution of acoustic modeling units, we took a dual approach that combines advanced data augmentation with architectural and training-level enhancements. Regarding the data, we created sentence-level, non-semantic corpora through lexical concatenation. This was supplemented by spectral augmentation, speed perturbation, noise injection, and voice conversion. At the model level, we optimized the Conformer backbone by introducing dilated convolutions and adaptive pooling in the downsampling layer to improve temporal resolution and feature richness. We employed a customized hybrid loss function that integrates CTC and phoneme classification losses alongside an adaptive learning rate scheduler, which makes the model more stable and fast convergence. Additionally, we proposed a novel scheme that uses target language bootstrapping to alleviate the distribution problem of acoustic modeling units further. Experiments conducted in a high-speed electronic environment demonstrate an 8.8% absolute reduction in word error rate (WER) compared with Wav2vec 2.0 and Transformer baselines. This research not only advances multilingual speech translation under AI paradigms but also bridges the gap between software model innovation and hardware-level optimization, offering a scalable, plug-in-ready solution for low-resource language preservation in modern intelligent systems.


  • Open Access

    The global prevalence and genetic spectrum of primary carnitine deficiency

    by Liu Sun, Ke Yao, Hang-Jing Wu

    Primary carnitine deficiency (PCD) is an autosomal recessive rare disorder of carnitine cycle and carnitine transport caused by pathogenic variants in the SLC22A5 gene. The prevalence of PCD is unclear. This study aimed to estimate the carrier frequency and genetic prevalence of PCD using Genome Aggregation Database (gnomAD) data. The pathogenicity of SLC22A5 variants was interpreted according to the American College of Medical Genetics and Genomics (ACMG) standards and guidelines. The minor allele frequency (MAF) of the variants of the SLC22A5 gene in 807,162 individuals was examined to estimate the global prevalence of PCD in nine ethnicities: African/African American (afr), Admixed American (amr), East Asian (eas), Non-Finnish European (nfe), South Asian (sas), Ashkenazi Jewish (asj), Middle Eastern (mid), Finnish (fin) and Remaining individuals (rmi). The global and population-specific carrier frequency and genetic prevalence of PCD were calculated using the Hardy–Weinberg equation. Total of 213 pathogenic/likely pathogenic variants (PV/LPV) of the SLC22A5 gene were identified according to the ACMG standards and guidelines. The global carrier frequency and genetic prevalence of PCD were 10.6 per thousand (1/95) and 28.2 per million (1/35427), respectively. The prevalence of PCD is estimated to be 1/35,000 globally, with a range of between 1/450,000 and 1/20,000 depending on ethnicity.


  • Open Access

    Tracking of Close Contacts of Highly Pathogenic Infectious Diseases Based on Blockchain and Mobile Signaling Data

    by Jian Yang, Lifang Zhang, Liu Sun, Zengfang Yang

    Early identification and isolation of confirmed patients and close contacts is one of the most effective methods to defeat highly pathogenic infectious diseases. However, existing close contact tracing methods have coarse spatio-temporal coverage and are difficult to accurately track. To address this issue, a novel close contact tracing method based on mobile signaling data is proposed, combined with Blockchain (BC) and interplanetary file system (IPFS) to achieve secure data sharing and distributed queries for close contacts. Experimental results on simulation data show that compared with existing epidemiological manual and semi-manual investigation methods, this method can provide more complete and comprehensive spatio-temporal coverage under the premise of ensuring data privacy and security, improve the accuracy of epidemiological investigation, and provide strong support for epidemic prevention and control.

  • Open Access

    The global prevalence and genetic spectrum of primary carnitine deficiency

    by Liu Sun, Hang-Jing Wu

    Background Primary carnitine deficiency (PCD) is an autosomal recessive rare disorder of carnitine cycle and carnitine transport caused by mutations in the SLC22A5 gene. The prevalence of PCD is unclear. This study aimed to estimate the carrier frequency and genetic prevalence of PCD using Genome Aggregation Database (gnomAD) data. Methods The pathogenicity of SLC22A5 variants was interpreted according to the American College of Medical Genetics and Genomics (ACMG) standards and guidelines. The minor allele frequency (MAF) of the disease-causing variants of the SLC22A5 gene in 807,162 individuals was examined to estimate the global prevalence of PCD in five major ethnicities: African (afr), Admixed American (amr), East Asian (eas), Non-Finnish European (nfe) and South Asian (sas). The global and population-specific carrier frequencies and genetic prevalence of PCD were calculated using the Hardy–Weinberg equation. Results Total of 195 pathogenic/likely pathogenic variants (PV/LPV) of the SLC22A5 gene were identified according to the ACMG standards and guidelines. The global carrier frequency and genetic prevalence of PCD were 1/88 and 1/31,260, respectively. Conclusions The prevalence of PCD is estimated to be 1/30,000 globally, with a range of between 1/20,000 and 1/70,000 depending on ethnicity.

  • Open Access

    The global prevalence and genetic spectrum of primary carnitine deficiency

    by Liu Sun, Hang-Jing Wu

    Background: Primary carnitine deficiency (PCD) is an autosomal recessive rare disorder of carnitine cycle and carnitine transport caused by mutations in the SLC22A5 gene. The prevalence of PCD is unclear. This study aimed to estimate the carrier frequency and genetic prevalence of PCD using Genome Aggregation Database (gnomAD) data. Methods: The pathogenicity of SLC22A5 variants was interpreted according to the American College of Medical Genetics and Genomics (ACMG) standards and guidelines. The minor allele frequency (MAF) of SLC22A5 gene disease-causing variants in 807,162 unique individuals was examined to estimate the global prevalence of PCD in five major ethnicities: African (afr), Admixed American (amr), East Asian (eas), Non-Finnish European (nfe) and South Asian (sas). The global and population-specific carrier frequencies and genetic prevalence of PCD were calculated using the Hardy–Weinberg equation. Results: In total, 195 pathogenic/likely pathogenic variants (PV/LPV) were identified according to ACMG standards and guidelines. The global carrier frequency and genetic prevalence of PCD were 1/88 and 1/31,260, respectively. Conclusions: The prevalence of PCD is estimated to be 1/30,000 globally, with a range of between 1/20,000 and 1/70,000 depending on ethnicity.


  • Open Access

    The global prevalence and ethnic heterogeneity of iron-refractory iron deficiency anaemia

    by Shanghua Fan, Ting Zhao, Liu Sun

    Background: Iron-refractory iron deficiency anaemia (IRIDA) is an autosomal recessive iron deficiency anaemia caused by mutations in the TMPRSS6 gene. Iron deficiency anaemia is common, whereas IRIDA is rare. The prevalence of IRIDA is unclear. This study aimed to estimate the carrier frequency and genetic prevalence of IRIDA using Genome Aggregation Database (gnomAD) data. Methods: The pathogenicity of TMPRSS6 variants was interpreted according to the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) standards and guidelines. The minor allele frequency (MAF) of TMPRSS6 gene disease-causing variants in 141,456 unique individuals was examined to estimate the global prevalence of IRIDA in seven ethnicities: African/African American (afr), American Admixed/Latino (amr), Ashkenazi Jewish (asj), East Asian (eas), Finnish (fin), Non-Finnish European (nfe) and South Asian (sas). The global and population-specific carrier frequencies and genetic prevalence of IRIDA were calculated using the Hardy–Weinberg equation. Results: In total, 86 pathogenic/likely pathogenic variants (PV/LPV) were identified according to ACMG/AMP guideline. The global carrier frequency and genetic prevalence of IRIDA were 2.02 per thousand and 1.02 per million, respectively. Conclusions: The prevalence of IRIDA is greater than previous estimates.


  • Open Access

    A Comprehensive Survey of Security Issues of Smart Home System: “Spear” and “Shields,” Theory and Practice

    by Jian Yang, Liu Sun

    The rapid development and wide application of the Internet of Things (IoT) and sensor technologies have produced good opportunities for the development of IoT-based smart home systems (SHSs). However, during the rapid market expansion of SHSs, security challenges associated with SHSs have become a primary concern of people because they are so closely related to people’s daily lives. These security problems may damage information assets and pose a serious threat to people’s health and life. This study investigates security issues in SHSs and provides a comprehensive overview of research to date. In this review, after analyzing the existing definition and concept of SHSs proposed by authoritative encyclopedias and academic literature, we propose a more accurate, elaborated definition of SHSs, analyze their architecture, extract six natural and contextual features, and summarize spears (cyber-attack means) vs. shields (countermeasures) in detail in the context of SHSs. Then, the security frameworks and evaluation technologies in SHSs are discussed. Different scenarios for technology integration and the practical research results in SHSs, such as blockchain, cloud computing, Internet of Vehicles, and AI are presented meticulously. After that, two special issues related to security are discussed. We believe that future research on SHS security should focus on four aspects: the unification of architecture, resource limitation, fragmentation, and code and firmware security. In addition, research on SHS security should be given priority over its commercialization process.


  • Open Access

    The global prevalence and ethnic heterogeneity of iron-refractory iron deficiency anaemia

    by Shanghua Fan, Ting Zhao, Liu Sun

    Background: Iron-refractory iron deficiency anaemia (IRIDA) is an autosomal recessive iron deficiency anaemia caused by mutations in the TMPRSS6 gene. Iron deficiency anaemia is common, whereas IRIDA is rare. The prevalence of IRIDA is unclear. This study aimed to estimate the carrier frequency and genetic prevalence of IRIDA using Genome Aggregation Database (gnomAD) data. Methods: The pathogenicity of TMPRSS6 variants was interpreted according to the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) standards and guidelines. The minor allele frequency (MAF) of TMPRSS6 gene disease-causing variants in 141456 unique individuals was examined to estimate the global prevalence of IRIDA in seven ethnicities: African/African American (afr), American Admixed/Latino (amr), Ashkenazi Jewish (asj), East Asian (eas), Finnish (fin), Non-Finnish European (nfe) and South Asian (sas). The global and population-specific carrier frequencies and genetic prevalence of IRIDA were calculated using the Hardy-Weinberg equation. Results: In total, 86 pathogenic/likely pathogenic variants (PV/LPV) were identified according to ACMG/AMP guideline. The global carrier frequency and genetic prevalence of IRIDA were 2.02 per thousand and 1.02 per million, respectively. Conclusions: The prevalence of IRIDA is greater than previous estimates.